BioSpace News Archive

Schweiger Dermatology Group’s lead hair transplant surgeon is recognized in New York magazine’s ‘Best Doctors’ issue for the 20th consecutive year.

JSR affiliate companies Crown Bioscience, KBI Biopharma, Inc., Medical & Biological Laboratories Co., LTD., Selexis SA and other affiliates throughout Europe and the Asia-Pacific region.

Brex Continues Vertical Growth Strategy Bringing Personalized Value to Biotechnology and Life Sciences Companies

In a report published this month, U.S. News & World Report and Pharmacy Times® confirm that two-thirds of pharmacists recommend After Bite® for treating insect bites and stings.

The abstract titled “Risk stratification in early stage luminal breast cancer patients treated with and without RT” shows that PreludeDx’s newly-developed assay can stratify risk of local recurrence in luminal stage 1 breast cancer patients.

Findings published in JNCCN confirm feasibility and necessity for institutional teams to provide rapid referrals for adverse events via an electronic method

Mill Creek Life Sciences, LLC (Mill Creek), a Rochester, MN based start-up that supports the development and application of cellular and biological therapeutics, has received a one-year $100,000 grant from Regenerative Medicine Minnesota (RMM) titled: “Development of Technology for the Large-scale Production of a Novel Dendritic Cell Vaccine for the Treatment of Glioblastoma.”

Three years ago, the U.S. Food and Drug Administration announced the most comprehensive reform to the Nutrition Facts label since its introduction in 1993.

With the help of philanthropic support for regenerative medicine and biomedical research, Dr. Robin Robinson, Ph.D., the first director of the Biomedical Advanced Research and Development Authority (BARDA) and former deputy Assistant Secretary for Preparedness and Response at the Department of Health and Human Services (HHS), was named a Fellow with the Thought Leadership & Innovation Foundation (TLI)

An estimated 7 million Americans have scoliosis*—that’s why Luke Stikeleather, National Scoliosis Center (NCS) Founder and President says: